Published in Intervirology on January 01, 1976
Human cytomegalovirus DNA replicates after early circularization by concatemer formation, and inversion occurs within the concatemer. J Virol (1994) 1.63
In vitro processing of herpes simplex virus type 1 DNA replication intermediates by the viral alkaline nuclease, UL12. J Virol (1998) 1.29
Structure of replicating herpes simplex virus DNA. J Virol (1981) 1.20
Focus formation and neoplastic transformation by herpes simplex virus type 2 inactivated intracellularly by 5-bromo-2'-deoxyuridine and near UV light. J Virol (1981) 0.88
Structure of the herpes simplex virus 1 genome: manipulation of nicks and gaps can abrogate infectivity and alter the cellular DNA damage response. J Virol (2014) 0.84
Initiation of lytic DNA replication in Epstein-Barr virus: search for a common family mechanism. Future Virol (2010) 0.82
Replication of herpes simplex virus type I DNA in permeabilized infected cells. Nucleic Acids Res (1980) 0.79
Diagnosis, screening and management of cystic fibrosis related diabetes mellitus: a consensus conference report. Diabetes Res Clin Pract (1999) 2.32
Interactions of human cytomegalovirus with human fibroblasts. J Bacteriol (1966) 2.00
Accumulation of defective viral genomes in peripheral blood mononuclear cells of human immunodeficiency virus type 1-infected individuals. J Virol (1997) 2.00
Thymidine-kinase in cytomegalovirus infected cells. Arch Virol (1976) 1.96
Temperature-sensitive mutants of herpes simplex virus. Virology (1970) 1.83
Correlation between infectivity and physical virus particles in human cytomegalovirus. J Bacteriol (1966) 1.71
Thermoinactivation of human cytomegalovirus. J Bacteriol (1966) 1.56
Human cytomegalovirus: properties of the complement-fixing antigen. J Immunol (1966) 1.44
Antibodies in human sera to soluble and viral antigens found in Burkitt lymphoma and other lymphoblastoid cell lines. J Natl Cancer Inst (1970) 1.43
WHO collaborative studies on poliovirus type 3 strains isolated during the 1968 poliomyelitis epidemic in Poland. Bull World Health Organ (1972) 1.42
Studies on the intracellular replicating DNA of herpes simplex virus type 1. Virology (1977) 1.40
Distinctive pattern of infection and replication of HIV1 strains in blood-derived macrophages. Virology (1992) 1.39
Ribonucleotides linked to DNA of herpes simplex virus type 1. J Virol (1974) 1.28
Papovaviridae. Intervirology (1974) 1.26
Sotalol-induced delayed ventricular repolarization in man. Eur Heart J (1980) 1.22
Early DNA-binding polypeptides of Epstein-Barr virus. Virology (1981) 1.15
Prospective study on the relationship between cervical neoplasia and herpes simplex type-2 virus. II. Herpes simplex type-2 antibody presence in sera taken at enrollment. Int J Cancer (1984) 1.14
Induction of NF-KB during monocyte differentiation by HIV type 1 infection. J Immunol (1991) 1.10
Association of some supraglottic laryngeal carcinomas with EB virus. Int J Cancer (1983) 1.07
Studies on the growth of herpes simplex virus in lymphoblastoid cells. Acta Virol (1971) 1.06
Increased oncogenicity and synthesis of herpesvirus antigens in hamster cells exposed to herpes simplex type-2 virus. J Natl Cancer Inst (1973) 1.05
Sero-epidemiology of the Epstein-Barr virus: preliminary analysis of an international study - a review. IARC Sci Publ (1975) 1.03
Late onset of total eversion of the upper eyelids. Ann Ophthalmol (1982) 1.01
Human transformed trophoblast-derived cells lacking CD4 receptor exhibit restricted permissiveness for human immunodeficiency virus type 1. J Virol (1991) 1.00
Presence of Epstein-Barr virus DNA in carcinomas of the palatine tonsil. J Natl Cancer Inst (1984) 1.00
Synthesis of thymidine kinase (TK) in Epstein-Barr virus-superinfected Raji TK-negative cells. Intervirology (1981) 0.99
Modified HPV16 E7 Genes as DNA Vaccine against E7-Containing Oncogenic Cells. Virology (2001) 0.98
Relationship between Epstein-Barr virus-determined complement-fixing antigen and nuclear antigen detected by anticomplement fluorescence. J Natl Cancer Inst (1974) 0.97
Productive infection of CD4+ cells by selected HIV strains is not inhibited by anti-CD4 monoclonal antibodies. Virology (1991) 0.95
Absence of cytomegalovirus DNA from adenocarcinoma of the colon. Intervirology (1980) 0.92
Longitudinal follow-up of antibody response to selected antigens of human papillomaviruses and herpesviruses in patients with invasive cervical carcinoma. Int J Cancer (2000) 0.91
The use of an in vitro test of delayed type hypersensitivity for the detection of specific tumor antigen of transplantation type induced by SV 40 virus. Z Immunitatsforsch Allerg Klin Immunol (1968) 0.91
Production of HIV-1 by resting memory T lymphocytes. AIDS (2001) 0.90
Replication of cytomegalovirus in human epitheloid diploid cell line. Arch Virol (1976) 0.90
Mapping of serologically relevant regions of human cytomegalovirus phosphoprotein pp150 using synthetic peptides. J Gen Virol (1991) 0.90
Prediction of relapse by day 100 BCR-ABL quantification after allogeneic stem cell transplantation for chronic myeloid leukemia. Leukemia (2006) 0.89
Human papillomavirus genotype spectrum in Czech women: correlation of HPV DNA presence with antibodies against HPV-16, 18, and 33 virus-like particles. J Med Virol (1999) 0.89
Phosphonylmethyl ethers of acyclic nucleoside analogues: inhibitors of HSV-1 induced ribonucleotide reductase. Antiviral Res (1990) 0.89
Primary intestinal epithelial cells can be infected with laboratory-adapted strain HIV type 1 NDK but not with clinical primary isolates. AIDS Res Hum Retroviruses (1998) 0.88
The human immunodeficiency virus (HIV) gag gene product p18 is responsible for enhanced fusogenicity and host range tropism of the highly cytopathic HIV-1-NDK strain. J Virol (1992) 0.88
Comparison of genetic properties of influenza viruses before and after repeated passages in monkey kidney cell culture. Acta Virol (1968) 0.88
Absence of cytomegalovirus, Epstein-Barr virus, and papillomavirus DNA from adenoma and adenocarcinoma of the colon. Acta Virol (1988) 0.88
Preparation of antisera against the S antigen of influenza A virus by immunization of guinea pigs with internal S antigen. Arch Gesamte Virusforsch (1967) 0.87
The concept of enactment and theoretical convergence. Psychoanal Q (1998) 0.87
Comparison of ELISA and western blotting for human papillomavirus type 16 E7 antibody determination. J Gen Virol (1991) 0.87
Structural variability of env and gag gene products from a highly cytopathic strain of HIV-1. Arch Virol (1992) 0.87
Determination of herpes simplex virus type-specific antibodies by solid-phase RIA on Helix pomatia lectin-purified antigens. J Infect Dis (1984) 0.87
Effects of n-butyrate and phorbol ester (TPA) on induction of Epstein-Barr virus antigens and cell differentiation. Arch Virol (1984) 0.87
Prospective study on the relationship between cervical neoplasia and herpes simplex type-2 virus. I. Epidemiological characteristics. Int J Cancer (1984) 0.86
Synthetic peptides derived from E7 region of human papillomavirus type 16 used as antigens in ELISA. J Gen Virol (1990) 0.86
Properties of a new type 3 attenuated poliovirus. VI. Alimentary tract resistance in children fed previously with type 3 Sabin vaccine to reinfection with homologous and heterologous type 3 attenuated poliovirus. Arch Gesamte Virusforsch (1967) 0.86
Variation in neurovirulence of NWS influenza virus after repeated passages in different tissue culture systems. I. Derivation and neurotropic activity of NWS virus lines. Arch Gesamte Virusforsch (1968) 0.86
Serological response to HPV16 in CIN-III and cervical cancer patients. Case-control studies in Spain and Colombia. Int J Cancer (1996) 0.85
Human papillomavirus infection and cervical carcinoma. Clin Obstet Gynecol (2000) 0.85
A new type 3 attenuated poliovirus for possible use in oral poliovirus vaccine. Prog Med Virol (1967) 0.85
Multiplicity reactivation in UV-irradiated herpes simplex type 1 virus. Intervirology (1973) 0.85
Lectin effects on HIV-1 infectivity. Ann N Y Acad Sci (1994) 0.85
Fusogenic determinants of highly cytopathic subtype D Zairian isolate HIV-1 NDK. Virology (1995) 0.84
Linkage between reproductive capacity at increased temperature and neurotropic activity in A-NWS HONi (HON1) influenza virus. Infect Immun (1974) 0.84
Human papillomavirus DNA and antibodies to human papillomaviruses 16 E2, L2, and E7 peptides as predictors of survival in patients with squamous cell cervical cancer. J Clin Oncol (1997) 0.84
Search for optimal parent for recombinant vaccinia virus vaccines. Study of three vaccinia virus vaccinal strains and several virus lines derived from them. Vaccine (1995) 0.83
Properties of a new type 3 attenuated poliovirus. V. Neurovirulence tests in monkeys after a passage through the human alimentary tract. Arch Gesamte Virusforsch (1965) 0.83
Presence of Epstein-Barr virus DNA in tonsillar tissues. Acta Virol (1981) 0.83
Plaque formation by NWS influenza virus in a human diploid cell strain. Acta Virol (1967) 0.83
Antibodies to EB virus capsid antigen and to soluble antigen of lymphoblastoid cells in infectious mononucleosis patients. Int J Cancer (1972) 0.83
Bactericidal activity of phenoxymethylpenicillin in an in-vitro model simulating tissue kinetics. J Antimicrob Chemother (1985) 0.83
Herpes simplex type 2 virus and cervical neoplasia. Adv Cancer Res (1987) 0.83
Effect of 3-beta-hydroxysteroid dehydrogenase gene deletion on virulence and immunogenicity of different vaccinia viruses and their recombinants. Arch Virol (1998) 0.83
Prevalence of antibodies to human papillomaviruses in the general population of the Czech Republic. Int J Cancer (1998) 0.83
Effect of long term treatment with metoprolol and sotalol on ventricular repolarisation measured by use of transoesophageal atrial pacing. Br Heart J (1986) 0.83
Metastatic MHC class I-negative mouse cells derived by transformation with human papillomavirus type 16. Br J Cancer (2001) 0.82
Some properties of the soluble (S) antigen of cultured lymphoblastoid cell lines. Arch Gesamte Virusforsch (1970) 0.82
Interleukin 2 gene therapy of residual disease in mice carrying tumours induced by HPV 16. Int J Oncol (1999) 0.82
Lectin-mediated effects on HIV type 1 infection in vitro. AIDS Res Hum Retroviruses (1995) 0.82
Structure of herpes simplex virus DNA: topography of the molecule. I. Absence of circularly permuted sequences. Virology (1975) 0.82
Clinical reactivity and immunogenicity of hemagglutinin influenza vaccine. I. Clinical reactions, hemagglutination-inhibiting and strain and type-specific complement-fixing antibody responses in subjects aged 3-6, 16-17 and 27-50 years. Arch Gesamte Virusforsch (1972) 0.82
Restriction of HIV-1 replication in intestinal cells is genetically controlled by the gag-pol region of the HIV-1 genome. Virology (1995) 0.82
Expression of an immunogenic region of HIV by a filamentous bacteriophage vector. Gene (1991) 0.82
Hydronephrosis and polycythemia. Urology (1983) 0.82
Prospective study on cervical neoplasia: presence of HPV DNA in cytological smears precedes the development of cervical neoplastic lesions. Sex Transm Infect (2003) 0.81
Presence of antibodies to seven human papillomavirus type 16-derived peptides in cervical cancer patients and healthy controls. J Infect Dis (1994) 0.81
Electron microscopy of binding of Epstein-Barr virus (EBV) nuclear antigen (EBNA-1) to EBV DNA. Virology (1987) 0.81
The env gene variability is not directly related to the high cytopathogenicity of an HIV1 variant. Virology (1990) 0.81